More Australians with cystic fibrosis can get the drug Trikafta cheaply from 1 July 2025 under the PBS.
Key Facts
- Drug: Trikafta
- Change from: 1 July 2025
- For people aged 2 and over with at least one responsive mutation
- Without subsidy: more than $250,000 a year
- PBS cost: up to $31.60, or $7.70 with a concession card
Correction
The $250,000 cost applies without the PBS subsidy. With the listing, patients pay the PBS price.
Frequently Asked Questions
What is Trikafta?
A medicine for cystic fibrosis.
How much does it cost on the PBS?
Up to $31.60, or $7.70 with a concession card.
Who is eligible?
People aged 2 and over with a responsive mutation.
Conclusion
The change makes the drug affordable for more families.
Related reads: La Toya Jackson Sparks Health Concerns After New Photos Reveal Dramatic Weight Loss; Health Star Ratings May Become Mandatory as Industry Falls Short; MAFS’ Lyndall Grace Shares Her Cystic Fibrosis Journey.
Leave a Reply